Invention Grant
- Patent Title: Crystalline forms of a PI3K inhibitor
-
Application No.: US15150999Application Date: 2016-05-10
-
Publication No.: US09988401B2Publication Date: 2018-06-05
- Inventor: Yun-Long Li , Brian W. Metcalf , Hui-Yin Li
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D473/34 ; C07D513/04

Abstract:
The present invention is related to crystalline forms of (S)-7-(1-(9H-purin-6-ylamino) ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one which is a PI3K inhibitor useful in the treatment of cancer and other diseases.
Public/Granted literature
- US20160362425A1 CRYSTALLINE FORMS OF A PI3K INHIBITOR Public/Granted day:2016-12-15
Information query